v3.22.2.2
Condensed Consolidated Statements of Stockholder Equity - USD ($)
$ in Millions
Total
Total stockholder equity
Common stock 
Capital surplus
(Accumulated deficit) Retained earnings
Treasury stock
Cumulative translation adjustment
Defined benefit postretirement plans
Cash flow hedging derivative
Non-controlling interest
Balance at beginning of period at Dec. 31, 2020 $ 3,583.9 $ 3,525.6 $ 0.0 $ 4,310.2 $ (690.1) $ 0.0 $ 26.2 $ (120.3) $ (0.4) $ 58.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (55.9) (60.1)     (60.1)         4.2
Shares issued for Bisnode acquisition 158.9 158.9   158.9            
Equity-based compensation plans 21.7 21.7   22.0   (0.3)        
Pension adjustments, net of tax expense (benefit) 1.2 1.2           1.2    
Change in cumulative translation adjustment, net of tax expense (benefit) (63.2) [1] (64.8)         (64.8)     1.6
Net investment hedge derivative, net of tax expense [2] 0.0                  
Derivative financial instruments, net of tax expense (benefit) 0.7 [3] 0.7             0.7  
Payment to non-controlling interest (2.0)                 (2.0)
Balance at end of period at Sep. 30, 2021 3,645.3 3,583.2 0.0 4,491.1 (750.2) (0.3) (38.6) (119.1) 0.3 62.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments, tax expense (benefit) (1.7)                  
Derivative financial instrument, tax expense (benefit) 0.2                  
Balance at beginning of period at Jun. 30, 2021 3,648.6 3,587.9 0.0 4,482.4 (766.8) (0.3) (8.3) (119.5) 0.4 60.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 18.2 16.6     16.6         1.6
Equity-based compensation plans 8.7 8.7   8.7            
Pension adjustments, net of tax expense (benefit) 0.4 0.4           0.4    
Change in cumulative translation adjustment, net of tax expense (benefit) (30.3) [1] (30.3)         (30.3)     0.0
Net investment hedge derivative, net of tax expense [2] 0.0                  
Derivative financial instruments, net of tax expense (benefit) (0.1) [3] (0.1)             (0.1)  
Payment to non-controlling interest (0.2)                 (0.2)
Balance at end of period at Sep. 30, 2021 3,645.3 3,583.2 0.0 4,491.1 (750.2) (0.3) (38.6) (119.1) 0.3 62.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments, tax expense (benefit) 1.3                  
Derivative financial instrument, tax expense (benefit) (0.1)                  
Balance at beginning of period at Dec. 31, 2021 3,745.3 3,681.2 0.0 4,500.4 (761.8) (0.3) (52.6) (11.9) 7.4 64.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (19.4) (25.1)     (25.1)         5.7
Equity-based compensation plans 38.7 38.7   38.7   0.0        
Dividends declared (21.8) (21.8)   (21.8) 0.0          
Pension adjustments, net of tax expense (benefit) (0.2) (0.2)           (0.2)    
Change in cumulative translation adjustment, net of tax expense (benefit) (220.0) [1] (212.8)         (212.8)     (7.2)
Net investment hedge derivative, net of tax expense 21.9 [2] 21.9         21.9      
Derivative financial instruments, net of tax expense (benefit) 43.4 [3] 43.4             43.4  
Payment to non-controlling interest (0.3)                 (0.3)
Balance at end of period at Sep. 30, 2022 3,587.6 3,525.3 0.0 4,517.3 (786.9) (0.3) (243.5) (12.1) 50.8 62.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments, tax expense (benefit) 6.9                  
Investment hedge, tax expense (benefit) 8.0                  
Derivative financial instrument, tax expense (benefit) 15.9                  
Balance at beginning of period at Jun. 30, 2022 3,645.7 3,582.1 0.0 4,521.6 (794.9) (0.3) (170.5) (12.1) 38.3 63.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 10.4 8.0     8.0         2.4
Equity-based compensation plans 17.5 17.5   17.5   0.0        
Dividends declared (21.8) [4] (21.8) [4]   (21.8) 0.0 [4]          
Change in cumulative translation adjustment, net of tax expense (benefit) (93.1) [1] (89.4)         (89.4)     (3.7)
Net investment hedge derivative, net of tax expense 16.4 [2] 16.4         16.4      
Derivative financial instruments, net of tax expense (benefit) 12.5 [3] 12.5             12.5  
Balance at end of period at Sep. 30, 2022 3,587.6 $ 3,525.3 $ 0.0 $ 4,517.3 $ (786.9) $ (0.3) $ (243.5) $ (12.1) $ 50.8 $ 62.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Foreign currency translation adjustments, tax expense (benefit) 4.0                  
Investment hedge, tax expense (benefit) 6.0                  
Derivative financial instrument, tax expense (benefit) $ 4.5                  
[1] Tax Expense (Benefit) of $(4.0) million and $(1.3) million for the three months ended September 30, 2022 and 2021, respectively. Tax Expense (Benefit) of $(6.9) million and $1.7 million for the nine months ended September 30, 2022 and 2021, respectively.
[2] Tax Expense (Benefit) of $6.0 million for the three months ended September 30, 2022. Tax Expense (Benefit) of $8.0 million for the nine months ended September 30, 2022.
[3] Tax Expense (Benefit) of $4.5 million and $(0.1) million for the three months ended September 30, 2022 and 2021, respectively. Tax Expense (Benefit) of $15.9 million and $0.2 million for the nine months ended September 30, 2022 and 2021, respectively.
[4] See Note 12 "Earnings (Loss) Per Share" for further discussion.